Terry Lynch

Terry Lynch discloses dealings in Quantum BioPharma Ltd. to SEDI. Over a trading history stretching from 26 March 2025 to 5 June 2025, the count stands at 2 filings.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The newest entry dates from 18 June 2025: a transaction, in Quantum BioPharma Ltd. This summary is built from SEDI disclosures alone and does not predict where the share price will go.